European Archives - Page 282 of 1119 - European Medical Journal

Evaluating Survival Outcomes of Systemic Anti-Cancer Therapy in Metastatic Cancer

Patients with certain cancers treated at practices using more systemic therapy did not have significantly improved survival outcomes compared to those treated at practices using less.

AI Analysis of Blood Tests Identifies Parkinson's Disease Years Before Motor Onset

Machine learning analysis of a panel of blood biomarkers accurately classified 79% of pre-motor patients up to seven years before the onset of motor symptoms.

Oral Contraceptive Pill Associated With Alopecia

A study shows oral contraceptive pill use affects the protective effect of the CYP1B1 variant against frontal fibrosing alopecia, increasing risk in females with OCP history.

Antibiotic Use in Infancy Linked to Atopic Dermatitis

Antibiotic use in early life has been associated with an increased risk of atopic dermatitis, likely due to gut microbiome disruption.

New Hope for Thalassemia: Mitapivat Triumphs in Global Trial

Study found Mitapivat significantly raised haemoglobin levels and alleviated fatigue in patients with non–transfusion-dependent thalassemia.

Hot Flash Severity Predicts Metabolic-Associated Liver Disease

Women experiencing hot flashes have been found to be more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease.

Predicting Sudden Cardiac Death with Heart Rate Variability

A novel heart rate variability analysis method, detrended fluctuation analysis, outperforms conventional tools in predicting sudden cardiac death, according to recent research.

Mortality Rates in Rheumatic Heart Disease

The risk of death is higher in patients with rheumatic heart disease in low/middle-income countries, with nearly 15% of patients dying within three years.

Vitamin D Supplements Prolong Treatment-Free Period for Chronic Leukaemia Patients

New study suggests that vitamin D supplements may significantly extend the treatment-free survival period for patients with asymptomatic chronic lymphocytic leukaemia

Novel Combination Therapy Shows Promising Results for Relapsed Multiple Myeloma

Belantamab combination therapy shows significant improvements in survival for relapsed/refractory multiple myeloma patients compared to pomalidomide plus bortezomib and dexamethasone